Coronavirus BRIEFING
Supported by Essilor

The Latest COVID-19 Data

COVID-19 Lockdown Effects on Adolescent Brain Structure Suggest Accelerated Maturation Is More Pronounced in Females Than in Males

By Staff
Wednesday, September 11, 2024 6:09 AM Lifestyle changes resulting from COVID-19 lockdowns in 2020 were linked with alterations in adolescents' brains, which were more pronounced among girls, a study suggested.

The National Average for Gross Revenue at ECP Locations Decreased for the Week of September 2–8, Jobson’s Latest Practice Performance Tracker Shows

By Staff
Wednesday, September 11, 2024 12:15 AM NEW YORK—The national average for gross revenue at ECP locations decreased last week, September 2–8, when compared with the previous week, at a rate of -17 index points due to the Labor Day holiday weekend. That places gross revenue at an equal index point level to where it was at this point in time (Week 36) when compared with last year (2023), 2 points above the same period in 2022, 13 points above 2021, 6 points above 2020 and 32 points above 2019, according to Jobson’s most recent Practice Performance Tracker.

New COVID-19 Vaccines Targeting KP.2 Variant Available

By Staff
Tuesday, September 10, 2024 8:02 AM New COVID-19 vaccines formulated for better protection against the currently circulating variants have been approved by the US Food and Drug Administration.

Updated COVID Vaccines: Who Should Get One, and When?

By Staff
Monday, September 9, 2024 8:02 AM New updated COVID vaccines are now available, but who can get them, who should get them, and when? Two updated mRNA COVID vaccines, one by Moderna and the other by Pfizer, have been authorized or approved by the US Food and Drug Administration (FDA) for those aged 6 months or older.

FDA OKs Updated Novavax COVID Shot

By Staff
Monday, September 9, 2024 6:09 AM The FDA granted emergency use authorization (EUA) for an updated Novavax COVID-19 vaccine to protect against hospitalization and death from circulating variants.

Pediatricians Scale Back on COVID Shots

By Staff
Thursday, September 5, 2024 8:02 AM When pediatrician Eric Ball opened a refrigerator full of childhood vaccines, all the expected shots were there—DTaP, polio, pneumococcal vaccine—except one. "This is where we usually store our COVID vaccines, but we don't have any right now because they all expired at the end of last year and we had to dispose of them," said Ball, who is part of a pediatric practice in Orange County, California.

The National Average for Gross Revenue at ECP Locations Decreased for the Week of August 26 – September 1, Jobson’s Latest Practice Performance Tracker Shows

By Staff
Thursday, September 5, 2024 12:24 AM NEW YORK—The national average for gross revenue at ECP locations decreased last week, August 26 – September 1, when compared with the previous week at a rate of -3 index points. That places gross revenue at a level 12 index points above where it was at this point in time (Week 35) when compared with last year (2023), 17 points above the same period in 2022, 26 points above 2021, 21 points above 2020 and 29 points above 2019, according to Jobson’s most recent Practice Performance Tracker.

Federal Funding for Free COVID Vaccines Has Ended

By Staff
Wednesday, September 4, 2024 7:59 AM A federal program that helped people get COVID-19 vaccines at no cost has ended. That means uninsured people may be asked to pay as much as $200 for the potentially life-saving shot.

With COVID, Not All Myocarditis Is Created Equal

By Staff
Tuesday, September 3, 2024 8:02 AM Welcome to Impact Factor, your weekly dose of commentary on a new medical study. I'm Dr F. Perry Wilson of the Yale School of Medicine.

Wegovy Protects Against Deadly COVID Cases

By Staff
Tuesday, September 3, 2024 6:09 AM The clinical benefits of semaglutide (Wegovy) went beyond expectations in the SELECT trial, given the reductions in non-cardiovascular and infectious disease deaths observed.

FDA Could Soon Limit Use of Only Drug for COVID Prevention

By Staff
Friday, August 30, 2024 6:09 AM Pemivibart (Pemgarda) should only be used for pre-exposure prophylaxis of COVID-19 in immunocompromised patients when the combined national frequency of SARS-CoV-2 variants with substantially reduced susceptibility to the drug is less than or equal to 90%, the FDA announced on Monday.

COVID-19 Booster Vaccine Shortens Menstrual Cycles in Teens

By Staff
Thursday, August 29, 2024 8:02 AM The COVID-19 booster was linked to shorter menstrual cycles in adolescent girls in the 4 months following administration, particularly when teens were in their follicular phase. The vaccine did not appear to be associated with shifts in menstrual flow, pain, or other symptoms.

An Unwelcome Souvenir From the Democratic National Convention: COVID

By Staff
Thursday, August 29, 2024 6:09 AM People often leave political conventions with lots of good memories and fun souvenirs, but some participants in the recent Democratic National Convention (DNC) in Chicago also brought home an unwelcome visitor: COVID-19.

Expert Epidemiologists on Everything COVID

By Staff
Thursday, August 29, 2024 6:09 AM In part 3 of this Instagram Live discussion, MedPage Today editor-in-chief Jeremy Faust, MD, Katelyn Jetelina, PhD, MPH, and Katrine Wallace, PhD, talk about the state of COVID in 2024, new research on long COVID and some positive points for the future.

The National Average for Gross Revenue at ECP Locations Decreased for the Week of August 19–25, Jobson’s Latest Practice Performance Tracker Shows

By Staff
Wednesday, August 28, 2024 12:24 AM NEW YORK—The national average for gross revenue at ECP locations decreased last week, August 19–25, when compared with the previous week at a rate of -1 index point. That places gross revenue at a level 19 index points above where it was at this point in time (Week 34) when compared with last year (2023), 19 points above the same period in 2022, 29 points above 2021, 23 points above 2020 and 28 points above 2019, according to Jobson’s most recent Practice Performance Tracker.